Zoetis Receives FDA Approval for Convenia® RTU for Dogs (cefovecin injectable suspension), Helping More Medium and Large Dogs Access Single-Injection Treatment
Tuesday, October 20, 2026 BiopharmaWatch Research 1 min read
Key Takeaway: Zoetis has received FDA approval for Convenia RTU for Dogs, an injectable suspension that provides up to 14 days of antibiotic treatment for susceptible bacterial skin infections. This single-dose treatment is designed to help more medium and large dogs access effective care. The approval marks a significant advancement in animal health.
Market Sentiment Analysis
POSITIVE FACTORS
FDA approval for Convenia RTU for Dogs
Single-injection treatment for medium and large dogs
Effective for up to 14 days of antibiotic treatment
Full Press Release Details
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Convenia RTU for Dogs provides up to 14 days of antibiotic treatment in a single dose for susceptible bacterial skin infections
Frequently Asked Questions
What is Convenia RTU for Dogs?
Convenia RTU is an injectable antibiotic treatment for bacterial skin infections.
How long does Convenia RTU last?
It provides up to 14 days of antibiotic treatment in a single dose.
Who can benefit from Convenia RTU?
Medium and large dogs with susceptible bacterial skin infections can benefit.